Bayesian Health
$25.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Bayesian Health is currently valued at $131.2M as of October 1, 2024. The company has raised a total of $40.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.28x, Bayesian Health has achieved a valuation that is 3.28 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Bayesian Health's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Bayesian Health Worth in 2025?
As of 2025, Bayesian Health is valued at $131.2M, based on the company's Later Stage VC funding round in October 1, 2024. This valuation positions Bayesian Health as one of the leading private companies in the sector.
Bayesian Health Valuation History
Bayesian Health's funding history demonstrates steady growth and investor confidence.
How Bayesian Health Valuation is Determined
Private company valuations like Bayesian Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Bayesian Health Valuation FAQs
Is Bayesian Health profitable?
Bayesian Health has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Bayesian Health's valuation compare to competitors?
Bayesian Health is valued at $131.2M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Bayesian Health IPO?
Bayesian Health has not announced plans for an initial public offering. Until an IPO, investors can access Bayesian Health shares through secondary market platforms.